Shopping Cart
Remove All
Your shopping cart is currently empty
hCAIX-IN-15, a potent inhibitor of human carbonic anhydrase IX (hCA IX), has an inhibition constant (Ki) of 38.8 nM and exhibits broad-spectrum anticancer activity suitable for cancer research [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | 8-10 weeks | 8-10 weeks | |
| 50 mg | Inquiry | 8-10 weeks | 8-10 weeks |
| Description | hCAIX-IN-15, a potent inhibitor of human carbonic anhydrase IX (hCA IX), has an inhibition constant (Ki) of 38.8 nM and exhibits broad-spectrum anticancer activity suitable for cancer research [1]. |
| Targets&IC50 | CA IX (human):38.8 nM (Ki) |
| In vitro | Compound 12i, designated as hCAIX-IN-15, exhibits potent cytotoxic effects after a 48-hour exposure on renal cancer (UO-31), breast cancer (MDA-MB-468), and non-small cell lung cancer (HOP-92) cell lines, with growth inhibition (GI%) values of 20%, 17%, and 16%, respectively [1]. |
| Molecular Weight | 411.41 |
| Formula | C18H14FN7O2S |
| Cas No. | 2849348-43-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.